Is MYSL or MRK a better dividend investment in 2026?

MYSL currently yields 25000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: MYSL offers higher current income.

What is the dividend yield difference between MYSL and MRK?

MYSL has a forward dividend yield of 25000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 24997.24 percentage points.

Home › Compare › MYSL vs MRK

MYSL vs MRK: Dividend Comparison 2026

MYSL yields 25000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MYSL wins by $481652020747103174656.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MYSL

● Live price

25000.00%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$481652020747103174656.00M

Annual income

$477,891,679,681,809,340,000,000,000.00

Full MYSL calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — MYSL vs MRK

📍 MYSL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MYSL	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MYSL + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MYSL pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MYSL

Annual income on $10K today (after 15% tax)

$2,125,000.00/yr

After 10yr DRIP, annual income (after tax)

$406,207,927,729,537,960,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, MYSL beats the other by $406,207,927,729,537,960,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MYSL + MRK for your $10,000?

MYSL: 50%MRK: 50%

100% MRK50/50100% MYSL

Portfolio after 10yr

$240826010373551587328.00M

Annual income

$238,945,839,840,904,670,000,000,000.00/yr

Blended yield

99.22%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MYSL

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MYSL buys

MRK buys

No recent congressional trades found for MYSL or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMYSLMRK

Forward yield	25000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$481652020747103174656.00M ✓	$56.8K
Annual income after 10y	$477,891,679,681,809,340,000,000,000.00 ✓	$9,798.13
Total dividends collected	$481404327977371041792.00M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: MYSL vs MRK ($10,000, DRIP)

Year	MYSL Portfolio	MYSL Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$2,510,700	$2,500,000.00	$11,206	$366.19	+$2.50M → MYSL
2	$589,298,599	$586,612,149.53	$12,650	$502.35	+$589.29M → MYSL
3	$129,309,604,119	$128,679,054,618.90	$14,407	$694.19	+$129309.59M → MYSL
4	$26,527,150,102,459	$26,388,788,826,051.22	$16,585	$967.82	+$26527150.09M → MYSL
5	$5,087,743,001,217,608	$5,059,358,950,607,977.00	$19,342	$1,363.89	+$5087743001.20M → MYSL
6	$912,316,496,169,531,500	$906,872,611,158,228,600.00	$22,913	$1,947.19	+$912316496169.51M → MYSL
7	$152,954,929,371,424,950,000	$151,978,750,720,523,570,000.00	$27,662	$2,823.89	+$152954929371424.91M → MYSL
8	$23,976,822,470,935,107,000,000	$23,813,160,696,507,682,000,000.00	$34,159	$4,173.35	+$23976822470935108.00M → MYSL
9	$3,514,337,444,199,857,700,000,000	$3,488,682,244,155,957,000,000,000.00	$43,337	$6,308.80	+$3514337444199857664.00M → MYSL
10	$481,652,020,747,103,200,000,000,000	$477,891,679,681,809,340,000,000,000.00	$56,776	$9,798.13	+$481652020747103174656.00M → MYSL

MYSL vs MRK: Complete Analysis 2026

MYSL — Stock

MyScreen Mobile, Inc. provides a tool for the mobile advertising market that brings permission and incentive marketing to cellular phone subscribers. It offers MyScreen Mobile that puts the mobile phone users in control of their advertising exposure and pays them for each ad viewed. The company's MyScreen Mobile enables subscribers to get paid for advertisements that appear on their phone. MyScreen Mobile, Inc. was formerly known as Nouveau International, Inc. and changed its name to MyScreen Mobile, Inc. in April 2007. My Screen Mobile, Inc. was incorporated in 1996 and is based in Toronto, Canada.

Full MYSL Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this MYSL vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MYSL vs SCHD MYSL vs JEPI MYSL vs O MYSL vs KO MYSL vs MAIN MYSL vs JNJ MYSL vs ABBV MYSL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.